When Food Poisoning Does Not End

You had food poisoning. The acute illness resolved within days. But weeks or months later, your gut still is not the same. You have bloating, irregular bowel habits, cramping, and a sensitivity to foods you previously tolerated without issue. If this describes your experience, you may have post-infectious irritable bowel syndrome (PI-IBS), a well-characterised condition that develops after an episode of acute gastroenteritis.

PI-IBS is not rare. Meta-analyses estimate that 10 to 17 percent of people who experience acute bacterial gastroenteritis go on to develop IBS symptoms that persist for months or years. The risk is higher with more severe initial infections, longer duration of acute illness, female sex, younger age, and pre-existing anxiety or depression.

What Happens to the Gut After Infection

Persistent Low-Grade Inflammation

Even after the infecting organism has been cleared, the immune system in the gut wall can remain activated. Biopsies from PI-IBS patients show increased mast cells, T-lymphocytes, and enteroendocrine cells in the intestinal mucosa months after the initial infection. This persistent low-grade inflammation disrupts normal gut function without being severe enough to show up on standard blood tests or endoscopy.

Altered Gut Permeability

Acute gastroenteritis damages the tight junctions between intestinal epithelial cells, increasing gut permeability. In most people, these tight junctions repair within weeks. In PI-IBS patients, increased permeability persists, allowing bacterial products and food antigens to activate the mucosal immune system and perpetuate symptoms.

Microbiome Disruption

The acute infection and the immune response it triggers significantly alter the gut microbiome. Key changes in PI-IBS include reduced microbial diversity, depletion of butyrate-producing bacteria, and potential development of small intestinal bacterial overgrowth (SIBO). Studies show that SIBO is present in a significant proportion of PI-IBS patients, likely because the infection damages the migrating motor complex that normally keeps the small intestine clear of excessive bacteria.

Enteric Nervous System Damage

The gut has its own nervous system containing as many neurons as the spinal cord. Acute infection can damage these neurons and alter their signalling patterns, leading to visceral hypersensitivity (increased pain perception from normal gut activity), altered motility, and disrupted communication between the gut and brain. This neurological component explains why PI-IBS often involves pain and discomfort out of proportion to any identifiable physical abnormality.

A key biomarker for PI-IBS is anti-CdtB antibodies, produced against cytolethal distending toxin B released by food-poisoning bacteria (Campylobacter, Salmonella, Shigella, E. coli). These antibodies cross-react with vinculin, a protein essential for migrating motor complex function, potentially explaining the persistent motility dysfunction in PI-IBS.

The Anti-Vinculin Connection

Research by Dr. Mark Pimentel at Cedars-Sinai has identified a specific autoimmune mechanism in PI-IBS. Bacteria that cause food poisoning produce cytolethal distending toxin B (CdtB). The immune system generates antibodies against CdtB, but these antibodies also target vinculin, a structural protein in the interstitial cells of Cajal that regulate gut motility. This molecular mimicry creates an autoimmune attack on the gut's pacemaker cells, disrupting the migrating motor complex and predisposing to SIBO and dysmotility.

Blood tests for anti-CdtB and anti-vinculin antibodies are now commercially available and can help confirm a PI-IBS diagnosis and distinguish it from inflammatory bowel disease.

Treatment Approaches for PI-IBS

Address SIBO if Present

Given the high prevalence of SIBO in PI-IBS, a lactulose breath test is recommended. If positive, targeted antibiotic therapy (rifaximin for hydrogen-dominant, rifaximin plus neomycin or metronidazole for methane-dominant) followed by prokinetic therapy to restore the migrating motor complex is the standard approach.

Dietary Management

A low-FODMAP diet reduces symptoms in approximately 70 percent of IBS patients and is particularly effective in PI-IBS. The diet should be implemented in three phases: strict elimination, systematic reintroduction, and long-term personalisation. Working with a FODMAP-trained dietitian optimises results.

Gut Barrier Repair

  • Glutamine supplementation (5 to 10 grams daily) supports intestinal tight junction integrity
  • Zinc carnosine has evidence for gastric and intestinal mucosal healing
  • Collagen peptides and bone broth provide amino acids for enterocyte repair

Nervous System Calming

Because PI-IBS involves visceral hypersensitivity and gut-brain axis dysfunction, neuromodulatory approaches can be highly effective:

  • Gut-directed hypnotherapy has the strongest evidence base for IBS symptom reduction
  • Low-dose tricyclic antidepressants (amitriptyline 10 to 25 mg) reduce visceral pain at doses far below those used for depression
  • Cognitive behavioural therapy specifically targeting gut-brain interactions

GutIQ can help you track whether your symptoms began after a specific infectious episode, monitor your response to treatment, and identify the dietary and lifestyle factors that most influence your PI-IBS symptoms over time.